A single 5g dose of psilocybin-containing mushrooms (Enigma strain) was associated with striking short-term functional improvements in an octogenarian with a decade-long history of advanced Alzheimer's disease, including the return of spontaneous speech, urinary continence, and independent movement. Psilocybin acts on serotonin 5-HT2A receptors to alter large-scale brain network dynamics and may promote structural neural plasticity, potentially making residual functional capa

A rigorous 18-week clinical trial found that daily consumption of maitake mushrooms significantly improved cognitive scores in healthy older adults, particularly in memory.

Alzheimer’s Disease (AD) is a pressing global challenge, with cases expected to triple globally, affecting around 152 million people by...